Title | Type | SJR | H index | Total Docs. (2008) | Total Docs. (3years) | Total Refs. (2008) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2008) | %Female (2008) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
182 | Chinese Journal of Clinical Oncology | journal | 0.100 Q4 | 11 | 328 | 1250 | 4249 | 13 | 1250 | 0.01 | 12.95 | 41.45 | |
181 | Advances in Gastrointestinal Cancers | journal | 0.101 Q4 | 1 | 25 | 71 | 523 | 0 | 35 | 0.00 | 20.92 | 38.10 | |
180 | Enhancer - Biotherapy of Cancer | journal | 0.101 Q4 | 0 | 0 | 43 | 0 | 0 | 21 | 0.00 | 0.00 | 0.00 | |
179 | Journal of Dalian Medical University | journal | 0.101 Q4 | 5 | 171 | 194 | 1759 | 1 | 194 | 0.01 | 10.29 | 44.98 | |
178 | Tumor | journal | 0.101 Q4 | 9 | 245 | 176 | 2890 | 4 | 176 | 0.02 | 11.80 | 36.71 | |
177 | Tumor Research | journal | 0.101 Q4 | 3 | 3 | 14 | 97 | 0 | 14 | 0.00 | 32.33 | 10.34 | |
176 | ecancermedicalscience | journal | 0.103 Q4 | 47 | 0 | 7 | 0 | 1 | 7 | 0.14 | 0.00 | 0.00 | |
175 | Women's Oncology Review | journal | 0.103 | 4 | 0 | 106 | 0 | 1 | 102 | 0.00 | 0.00 | 0.00 | |
174 | Voprosy Onkologii | journal | 0.104 Q4 | 13 | 128 | 380 | 2680 | 19 | 380 | 0.04 | 20.94 | 49.84 | |
173 | Annals of Cancer Research and Therapy | journal | 0.105 Q4 | 7 | 11 | 23 | 173 | 1 | 23 | 0.07 | 15.73 | 16.67 | |
172 | Oncology Reviews | journal | 0.105 Q4 | 31 | 40 | 20 | 2470 | 1 | 19 | 0.05 | 61.75 | 39.58 | |
171 | Turkish Journal of Cancer | journal | 0.108 Q4 | 10 | 29 | 84 | 605 | 3 | 84 | 0.02 | 20.86 | 41.96 | |
170 | Journal of Cell and Molecular Biology | journal | 0.112 Q4 | 13 | 6 | 19 | 332 | 2 | 17 | 0.11 | 55.33 | 18.18 | |
169 | Breast Cancer Online | journal | 0.113 Q4 | 3 | 13 | 45 | 258 | 5 | 45 | 0.11 | 19.85 | 45.45 | |
168 | Chinese Journal of Cancer Research (discontinued) | journal | 0.113 Q4 | 41 | 57 | 180 | 991 | 16 | 180 | 0.11 | 17.39 | 37.61 | |
167 | Chinese Journal of Lung Cancer | journal | 0.113 Q4 | 21 | 176 | 293 | 3061 | 33 | 293 | 0.09 | 17.39 | 35.31 | |
166 | Nowotwory | journal | 0.114 Q4 | 11 | 77 | 178 | 1524 | 22 | 175 | 0.07 | 19.79 | 33.49 | |
165 | Onkologia Polska | journal | 0.118 Q4 | 7 | 33 | 114 | 571 | 18 | 113 | 0.23 | 17.30 | 58.20 | |
164 | Cancer Forum | journal | 0.121 Q4 | 15 | 35 | 94 | 890 | 13 | 90 | 0.11 | 25.43 | 38.60 | |
163 | Cancer journal (Sudbury, Mass.) | journal | 0.122 Q4 | 102 | 73 | 212 | 3169 | 507 | 168 | 2.60 | 43.41 | 35.50 | |
162 | Clinical and Experimental Medical Letters | journal | 0.123 Q4 | 6 | 46 | 40 | 1093 | 3 | 40 | 0.08 | 23.76 | 40.29 | |
161 | Japanese Journal of Cancer and Chemotherapy | journal | 0.123 Q4 | 25 | 559 | 1411 | 640 | 188 | 1411 | 0.14 | 1.14 | 14.40 | |
160 | Biotherapy | journal | 0.126 Q4 | 8 | 55 | 190 | 1041 | 7 | 190 | 0.04 | 18.93 | 9.90 | |
159 | Reports of Practical Oncology and Radiotherapy | journal | 0.128 Q4 | 36 | 38 | 113 | 684 | 15 | 103 | 0.14 | 18.00 | 45.45 | |
158 | International Journal of Cancer Research (discontinued) | journal | 0.131 Q4 | 18 | 12 | 73 | 458 | 15 | 73 | 0.21 | 38.17 | 38.46 | |
157 | Current Hematologic Malignancy Reports | journal | 0.135 Q4 | 44 | 27 | 70 | 1233 | 3 | 68 | 0.04 | 45.67 | 29.03 | |
156 | Supportive Cancer Therapy | journal | 0.153 Q4 | 15 | 0 | 66 | 0 | 20 | 55 | 0.30 | 0.00 | 0.00 | |
155 | Brain Tumor Pathology | journal | 0.166 Q4 | 45 | 15 | 48 | 454 | 19 | 46 | 0.38 | 30.27 | 4.05 | |
154 | Advances in Breast Cancer | journal | 0.169 Q4 | 4 | 29 | 83 | 414 | 5 | 30 | 0.06 | 14.28 | 51.85 | |
153 | Current Cancer Therapy Reviews | journal | 0.169 Q4 | 17 | 38 | 62 | 3213 | 15 | 60 | 0.24 | 84.55 | 45.05 | |
152 | Update on Cancer Therapeutics | journal | 0.182 Q4 | 13 | 9 | 53 | 853 | 24 | 52 | 0.45 | 94.78 | 25.00 | |
151 | Journal of B.U.ON. | journal | 0.191 Q4 | 37 | 101 | 291 | 2582 | 145 | 270 | 0.58 | 25.56 | 35.67 | |
150 | National Toxicology Program technical report series | journal | 0.221 | 22 | 7 | 20 | 0 | 15 | 20 | 0.82 | 0.00 | 0.00 | |
149 | European Journal of Cancer, Supplement | journal | 0.235 Q4 | 29 | 48 | 224 | 1524 | 169 | 208 | 1.05 | 31.75 | 30.15 | |
148 | Journal of the Egyptian National Cancer Institute | journal | 0.253 Q4 | 28 | 23 | 104 | 0 | 53 | 103 | 0.37 | 0.00 | 44.83 | |
147 | Tumori | journal | 0.302 Q4 | 59 | 189 | 429 | 4346 | 351 | 403 | 0.82 | 22.99 | 36.81 | |
146 | Bulletin du Cancer | journal | 0.307 Q4 | 44 | 194 | 548 | 6150 | 498 | 487 | 0.92 | 31.70 | 40.65 | |
145 | Clinical and Translational Oncology | journal | 0.315 Q4 | 61 | 155 | 415 | 4810 | 290 | 360 | 0.81 | 31.03 | 44.03 | |
144 | Asian Pacific Journal of Cancer Prevention | journal | 0.318 Q4 | 91 | 159 | 385 | 4625 | 444 | 344 | 1.09 | 29.09 | 37.08 | |
143 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.351 Q4 | 50 | 8 | 24 | 1070 | 33 | 23 | 1.38 | 133.75 | 0.00 | |
142 | Targeted Oncology | journal | 0.351 Q4 | 59 | 33 | 63 | 1561 | 35 | 56 | 0.56 | 47.30 | 28.04 | |
141 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.400 Q4 | 56 | 37 | 50 | 1092 | 108 | 48 | 2.84 | 29.51 | 43.82 | |
140 | Experimental Oncology | journal | 0.409 Q3 | 48 | 63 | 191 | 1725 | 199 | 188 | 1.06 | 27.38 | 41.80 | |
139 | In Vivo | journal | 0.415 | 72 | 135 | 474 | 4031 | 592 | 472 | 1.06 | 29.86 | 31.26 | |
138 | Cancer Genomics and Proteomics | journal | 0.450 Q3 | 50 | 26 | 112 | 952 | 96 | 111 | 1.07 | 36.62 | 32.47 | |
137 | Cancer Treatment and Research | journal | 0.475 Q3 | 65 | 68 | 186 | 5057 | 194 | 186 | 0.99 | 74.37 | 35.09 | |
136 | Infectious Agents and Cancer | journal | 0.477 Q3 | 47 | 14 | 32 | 781 | 38 | 32 | 1.19 | 55.79 | 51.69 | |
135 | Human Cell | journal | 0.482 Q3 | 44 | 14 | 51 | 385 | 64 | 51 | 1.55 | 27.50 | 10.94 | |
134 | Cancer Informatics | journal | 0.491 Q3 | 37 | 34 | 83 | 1221 | 84 | 77 | 1.04 | 35.91 | 31.40 | |
133 | Oncology | journal | 0.491 Q3 | 83 | 218 | 647 | 3980 | 489 | 416 | 0.69 | 18.26 | 34.55 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®